Literature DB >> 21273318

Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis.

Emilie Faivre1, Victor A Gault, Bernard Thorens, Christian Hölscher.   

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a key incretin hormone, released from intestine after a meal, producing a glucose-dependent insulin secretion. The GIP receptor (GIPR) is expressed on pyramidal neurons in the cortex and hippocampus, and GIP is synthesized in a subset of neurons in the brain. However, the role of the GIPR in neuronal signaling is not clear. In this study, we used a mouse strain with GIPR gene deletion (GIPR KO) to elucidate the role of the GIPR in neuronal communication and brain function. Compared with C57BL/6 control mice, GIPR KO mice displayed higher locomotor activity in an open-field task. Impairment of recognition and spatial learning and memory of GIPR KO mice were found in the object recognition task and a spatial water maze task, respectively. In an object location task, no impairment was found. GIPR KO mice also showed impaired synaptic plasticity in paired-pulse facilitation and a block of long-term potentiation in area CA1 of the hippocampus. Moreover, a large decrease in the number of neuronal progenitor cells was found in the dentate gyrus of transgenic mice, although the numbers of young neurons was not changed. Together the results suggest that GIP receptors play an important role in cognition, neurotransmission, and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273318     DOI: 10.1152/jn.00866.2010

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  29 in total

1.  Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.

Authors:  Tetsade C B Piermartiri; Hongna Pan; Jun Chen; John McDonough; Neil Grunberg; James P Apland; Ann M Marini
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

2.  Temporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats.

Authors:  Ana Beatriz W Marcos; Stefania Forner; Alessandra C Martini; Eliziane S Patrício; Julia R Clarke; Robson Costa; João Felix-Alves; Vilberto José Vieira; Edinéia Lemos de Andrade; Tânia Longo Mazzuco; João Batista Calixto; Claudia Pinto Figueiredo
Journal:  J Neurotrauma       Date:  2015-12-23       Impact factor: 5.269

3.  Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.

Authors:  Paul B Higgins; Robert E Shade; Irám P Rodríguez-Sánchez; Magdalena Garcia-Forey; M Elizabeth Tejero; V Saroja Voruganti; Shelley A Cole; Anthony G Comuzzie; Franco Folli
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-16       Impact factor: 4.310

4.  Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Jayasankar Kosaraju; R M Damian Holsinger; Lixia Guo; Kin Yip Tam
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

5.  Hippocampal subregions exhibit both distinct and shared transcriptomic responses to aging and nonneurodegenerative cognitive decline.

Authors:  Dustin R Masser; Georgina V Bixler; Robert M Brucklacher; Han Yan; Cory B Giles; Jonathan D Wren; William E Sonntag; Willard M Freeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-02       Impact factor: 6.053

6.  Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yazhou Li; Harold W Holloway; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Alzheimers Dement       Date:  2015-08-29       Impact factor: 21.566

7.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

Review 8.  New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders.

Authors:  Nigel Irwin; Peter R Flatt
Journal:  World J Diabetes       Date:  2015-11-10

9.  Neural stem cells in the diabetic brain.

Authors:  Tomás P Bachor; Angela M Suburo
Journal:  Stem Cells Int       Date:  2012-11-14       Impact factor: 5.443

10.  Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.

Authors:  Emilie Faivre; Christian Hölscher
Journal:  Alzheimers Res Ther       Date:  2013-04-19       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.